Patricia J. Sulak MD

PubMed

• 30 citations
  Extended Cycle Combined Oral Contraceptives and Prophylactic Frovatriptan During the Hormone-Free Interval in Women with Menstrual-Related Migraines
  Andrea Coffee, Patricia J. Sulak, Alexandria J Hill, Darci J Hansen, Thomas J. Kuehl
  Journal of Women's Health. 2014-04-07
• 17 citations
  Attitudes and prescribing patterns of extended-cycle oral contraceptives.
  Divya L. Seval, Terry Buckley, Thomas J. Kuehl, Patricia J. Sulak
  Contraception. 2011-07-01
• 54 citations
  Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.
  Patricia J. Sulak, Virginia J. Smith, Andrea Coffee, Iris Witt, Alicia L. Kuehl
  Obstetrics and Gynecology. 2008-09-01

Journal Articles

• Guidelines for Outpatient Family Planning Care.  
  Sulak PJ, Chez RA, Thorneycroft IH, Monograph for Health Professionals
• A New Way to Manage Menstruation.  
  Sulak PJ, The Female Patient
• Should your patient be on extended use OCs?  
  Sulak PJ, Contemporary OB/GYN

Books/Book Chapters

• Atlas of Clinical Gynecology. 
  Chapter: Dysfunctional Uterine Bleeding: Evaluation and Treatment 
  Sulak PJ, Yandell PMEditors: Stenchever MA, Mishell.
• PERIMENOPAUSE 
  Chapter: Contraceptive Needs and Options in Perimenopausal Women 
  Page 281 - 286Sulak PJEditors: Lobo R.New York
• PerimenopaulsaL Gynecology. 
  Chapter: Creative use of oral contraceptives in the perimenopausal patient 
  Sulak PJParthenon Publishing, NY

Abstracts/Posters

• Evaluation of the pituitary-ovarian axis suppression with three different oral contraceptive regimens.
  Sulak P, Kuehl T, Coffee A, Vandever M, Reape K, The ACOG ACM, San Diego, CA
• Current Clinical Issues in Oral Contraceptives.
  Sulak PJ, Contemporary Ob/Gyn, 1996; 41(12)(Supp
• Greater Inhibition of the Pituitary Ovarian Axis with a Shortened Hormone Free Interval.
  Willis S, Sulak P, Kuehl T, The Annual ASRM meeting, Philadelphia PA

Lectures

• Serum Hormone Levels, Bleeding Patterns, and Symptomatology in a 21/7 Versus Extended Regimen of a Drospirenone Containing Oral Contraceptive. 
  Presented at the 12th Annual Controversies in Gynecology, Venice Italy
• OCs: therapeutic uses and quality of life benefits. The Science of OCs and Todays Clinical Challenges. 
  Scientific Symposium at the American Society for Reproductive Medicine 54th Annual Meeting